As the novel coronavirus disease (COVID-19) provoked by the severe acute respiratory coronavirus 2 (SARS-CoV-2) keeps tearing the world apart, scientists are working continuously to produce medicine or vaccines fight off the deadly virus.
As more than 33.5 million people were infected since the pandemic’s beginning, discovering a cure for the infected population is imperative.
A New Hope
Ena Respiratory, an Australian biotech company, claimed that it is working on a nasal spray that might help boost the human immune system to combat flu and common colds. The spray reportedly decreased the growth of the coronavirus in a recent study in animals.
The spray may not only help treat COVID-19 but also prevent it!
The product is called INNA-051. The brainchild of Ena Respiratory and lab tests proved that it decreased viral replication by up to 96% in the animal study.
A new study spoke about potential treatment. It was published in the open-source preprint server bioRxiv.
The spray’s goal is to boost the body’s natural immune system to fight common colds and flu. It triggers the innate immune system, the body’s first line of defense against pathogens and infection.
The drug’s ability to enhance the immune system prevented the infection and replication of SARS-CoV-2 in laboratory tests.
Respiratory tract diseases, including the ones that provoke common colds, flu, and coronavirus infection, are significant threats to global health.
Such viruses resulted in outbreaks to pandemics, with the lives of millions at risk.
The SARS-CoV-2 infection is spreading quickly between people via close contact and respiratory droplets.
One of the most severe pandemic threats is asymptomatic people, also known as silent spreaders.